Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • eleanorFLG
    Junior Member
    • May 2015
    • 3

    #1

    Festival of Genomics, 3 - 5 November San Mateo 2015

    An event to define the future of genomics...
    The Festival of Genomics is a celebration of the transformational science of our age. If you’re a scientist, industry leader or clinician and share our aim of delivering the benefits of genomics to patients faster, this is the event that connects the dots.

    Just a few of our 100+ speakers:
    • Industry: Lorenz Mayr, AstraZeneca Innovative Medicines and Early Development & Joel Klappenbach, Merck Research Laboratories
    • Clinical: Robert Nussbaum, UCSF School of Medicine & Tom Fowler, Genomics England
    • Academia: Jennifer Doudna of University of California & Karen Nelson of J. Craig Venter Institute
    • Plus patient stories

    Investigate our 4 talk streams:
    • Genome Editing: The latest on CRISPR therapeutics and the ethics of genome editing
    Genome Analysis: Covering cutting edge NGS including single cell analysis . Perhaps the most relevant and interesting to those on this site.
    • Genomic Medicine: Overcoming the lag between technology and the clinic
    • Data Analysis: Tackling the need to match analysis with the rate of sequencing

    All from $150 for 2 Packed Days + $100 per workshop (Book before 31st July as prices are going up!)
    Register here

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Today, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 02:55 AM
0 responses
6 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...